RFK Jr.'s HHS Guidelines on SSRIs Spark Fierce Backlash from Psychiatric Community
核心洞察
HHS Secretary Robert F. Kennedy Jr. issued new federal guidelines in May 2026 targeting SSRI prescribing, including strengthened informed consent, deprescribing support, non-drug first approaches, and shorter prescribing windows.
A national survey of psychiatrists at the 2026 APA meeting found 97% believe RFK Jr. is unfit to serve as HHS Secretary and 94% say his policies have not benefited psychiatry.
Experts warn that Kennedy's rhetoric stigmatizes psychiatric medication and will disproportionately harm marginalized communities, with Black children specifically targeted in his comments.
The U.S. Department of Health and Human Services (搜索), under Secretary Robert F. Kennedy Jr., has issued a series of new federal guidelines regarding selective serotonin reuptake inhibitors that have ignited fierce opposition from the psychiatric community. The May 2026 directives, which Kennedy's Make America Healthy Again Commission previewed in February 2025, outline four key pillars: strengthened informed consent, more support for deprescribing, a whole-person non-drug first approach for mild to moderate depression (搜索), and shorter prescribing windows with regular reassessment.
The proposals, on their face, appear modest. "There's nothing particularly radical here," notes an analysis published in Psychology Today. Many mental health professionals have long acknowledged that alternatives to SSRIs (搜索) exist, including exercise, which a recent study showed is comparable and sometimes superior to SSRIs for mild to moderate depression (搜索).
Yet psychiatry's response has been one of overwhelming rejection. A national survey of psychiatrists conducted at the May 2026 meeting of the American Psychiatric Association in San Francisco found that 97% of psychiatrists believe RFK Jr. is not fit to serve as HHS Secretary, 94% believe his statements have not benefited psychiatry, and 97% believe the APA should take a stronger stance against him.
A Symbol Under Attack
To understand the intensity of the reaction, the Psychology Today analysis points to the symbolic power of SSRIs (搜索) within the profession. In the 1950s, psychiatry was in crisis, split between psychoanalysts and asylum doctors using extreme methods like insulin comas and lobotomies. The field was not considered a fully legitimate branch of medicine.
The paradigm shift came in the 1970s and 1980s, when psychiatry increasingly framed mental disorders as brain disorders to be managed with drugs. This culminated with the emergence of Prozac in 1988 and the now-discredited "chemical imbalance" narrative. SSRIs (搜索) became emblematic of psychiatry's claim to medical legitimacy.
"When you criticize SSRIs (搜索), you're not just criticizing one particular treatment among others. You're criticizing a status symbol," the analysis states. The guidelines, it concludes, "kicked the proverbial hornet's nest."
Misinformation and Stigmatization
Beyond the guidelines themselves, Kennedy's broader rhetoric has alarmed mental health professionals. He has falsely claimed that antidepressants induce homicidal ideation and are more addictive than heroin—statements Dr. Eric Rafla-Yuan, a psychiatrist and chair of the Committee to Protect Public Mental Health (搜索), described as "horrendously inaccurate misinformation."
Kennedy has specifically targeted Black children, stating on a 2024 podcast that "every Black kid is now just standard put on Adderall, SSRIs (搜索), benzos, which are known to induce violence," a claim he later denied. He has also suggested these children be "reparented" on "wellness farms," a suggestion with disturbing roots in eugenics and slavery.
In reality, studies have found that Black children are 70% less likely to receive an ADHD (搜索) diagnosis than white children. Black and Hispanic Americans seek mental health treatment at much lower rates than their white counterparts.
"Taking away medicine that improves the quality of life for individuals suffering from an array of mental health challenges, primarily those from marginalized backgrounds, is a form of structural violence," said Eboni Wooley, a psychotherapist and lecturer at New York University. "You are stripping away medication that many individuals need to meet their basic needs."
The Real Crisis: Access, Not Excess
The Committee to Protect Public Mental Health (搜索) released a guide stating: "Access, not excess, is the true crisis. Framing the problem as 'over-medication' distracts from the real issue—35% of adults and 50% of children and teenagers who needed mental health care report not being able to access it."
Dr. Lauren Osborne, vice chair of clinical research at the Obstetrics and Gynecology Department at Weill Cornell Medicine, emphasized that the larger issue is continued access to mental health care providers. "If you want to take away one tool, which is medication, you're going to have to increase the ability of people to access other kinds of treatments, and I haven't seen anything about that in RFK's rhetoric," she said.
Osborne noted that some patients go on psychiatric medication precisely because other mental health services, such as counseling, are unavailable—even to those with commercial insurance. Over a third of psychologists are not in-network with any insurance, according to the American Psychological Association.
"This is a disease of the brain, just like cardiomyopathy is a disease of the heart," Osborne said, adding that Kennedy's comments reflect a "fundamental misunderstanding of what psychiatric illness is."
Ripple Effects in Clinical Practice
While Kennedy's rhetoric has yet to legally restrict antidepressants, Osborne has observed tangible effects in her practice. Some patients, mostly pregnant or perinatal, have expressed heightened concern about discontinuing antidepressants. She is also encountering misinformation about "natural" treatments attributed to the MAHA movement.
"Some of my patients are, for example, very willing to use cannabis during pregnancy, even though we have a lot of information about the risks of that to the fetus … because it's natural, and they're not willing to take my FDA-regulated medication because it's not natural," Osborne said.
The stakes of stigmatizing psychiatric medication are high. A 2024 study in Health Affairs found that the wording and media amplification of a 2003 FDA safety warning about antidepressants may have led to thousands of deaths.
Rafla-Yuan characterized the HHS approach as a "Trojan horse" for a "crosscutting agenda to strip away access to care for millions of families." He emphasized that the administration is peddling dangerous misinformation about drug safety and efficacy while worsening social determinants of health, including access to clean water, nutritious food, quality education, livable wages, and safe living environments.
"We need all of these, not just medication or therapy, to really support healthy and thriving communities," Rafla-Yuan said.